Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Cadrenal Therapeutics Inc Nasdaq CVKD a biopharmaceutical company developing tecarfarin a latestage novel oral and reversible anticoagulant blood thinner to prevent heart attacks strokes and deaths due to blood clots in patients with certain rare med...
Denali Therapeutics Inc NASDAQ DNLI a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the bloodbrain barrier for the treatment of neurodegenerative diseases and lysosomal storage diseases today announc...
XORTX Therapeutics Inc XORTX or the Company NASDAQ XRTX TSXV XRTX Frankfurt ANU a latestage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease announces that it has submitted an Orphan Dru...
BioVaxys Technology Corp CSE BIOV OTCQB BVAXF LB FRA BioVaxys or the Company is pleased to announce that it has further extended its research collaboration with The Ohio State University The Ohio State for SARSCoV SARSCoV and pansarbecovirus vaccine...
Nufactor Inc a specialty pharmacy and subsidiary of FFF Enterprises Inc announced that it has partnered with Verrica Pharmaceuticals to be the exclusive specialty pharmacy to dispense YCANTH the first FDA approved treatment of molluscum contagiosum i...
Sandoz a global leader in generic and biosimilar medicines today announced that the US Food and Drug Administration FDA has approved its biosimilar Tyruko natalizumabsztn developed by Polpharma Biologics Tyruko is approved to treat all indications co...
Faron Pharmaceuticals Ltd a clinicalstage biopharmaceutical company focused on tackling cancers via novel immunotherapies today announces the US Food and Drug Administration FDA has granted
Lantern Pharma Inc an artificial intelligence AI company developing targeted and transformative cancer therapies using its proprietary AI and machine learning ML platform RADR with multiple clinical stage drug programs
Radiopharm Theranostics a developer of radiopharmaceutical products for both diagnostic and therapeutic uses is pleased to announce an expanded agreement with TerThera to supply
Oxford Biomedica plc LSEOXB Oxford Biomedica or the Company a quality and innovationled viral vector CDMO today announces that it has expanded its License and Supply Agreement LSA with Cabaletta Bio Inc Nasdaq CABA Cabaletta Bio a Philadelphiabased c...
